IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients



Palmieri, Carlo ORCID: 0000-0001-9496-2718, Stein, Rob C, Liu, Xinxue, Hudson, Emma, Nicholas, Hanna, Sasano, Hironobu, Guestini, Fouzia, Holcombe, Chris, Barrett, Sophie, Kenny, Laura
et al (show 6 more authors) (2017) IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients. BREAST CANCER RESEARCH AND TREATMENT, 165 (2). 343 - 353.

Access the full-text of this item by clicking on the Open Access link.
Item Type: Article
Uncontrolled Keywords: Breast cancer, Endocrine therapy, Sulfatase, Aromatase
Depositing User: Symplectic Admin
Date Deposited: 25 Jan 2019 14:42
Last Modified: 13 May 2021 16:10
DOI: 10.1007/s10549-017-4328-z
Open Access URL: https://link.springer.com/content/pdf/10.1007/s105...
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3031807